Suppr超能文献

[淋巴囊肿与肾移植]

[Lymphocele and kidney transplantation].

作者信息

Langer Róbert, Tóth András, Máthé Zsolt, Remport Adám, Járay Jeno, Kahan Barry D

机构信息

Semmelweis Egyetem, Altalános Orvostudományi Kar, Transzplantációs és Sebészeti Klinika, Budapest.

出版信息

Orv Hetil. 2007 Aug 5;148(31):1475-80. doi: 10.1556/OH.2007.28135.

Abstract

INTRODUCTION

Lymphocele is a special complication following kidney transplantation. The authors examined the factors associated with an increased occurrence of clinically significant perinephric fluid collections and/or lymphoceles among sirolimus-treated renal transplant recipients.

AIM

From the point of view of the lymphocele a comparison was made for the risks and benefits of the conventional and a newer immunosuppressive combination.

METHODS

At the University of Texas in Houston in a retrospective study the incidence, predisposing factors, and consequences of these fluid collections among patients treated with sirolimus-cyclosporine-prednisone ( n = 354, Group I) versus cyclosporine-prednisone-azathioprine ( n = 136, Group II) were compared.

RESULTS

More Group I patients (135/354; 38.1%) displayed perinephric fluid collections than Group II patients (24/136; 17.6%; p < 0.001). In both subgroups the serum creatinine levels were elevated at the time of diagnosis from a nadir of 179.5 +/- 141.7 to 359.9 +/- 259.6 mmol/l (Group III, sirolimus treated) and from 222.6 +/- 205.9 to 383.7 +/- 255.2 mmol/l (Group IV, sirolimus free). A significantly greater number of patients required treatment for lymphoceles among Group I (15.8%; 56/354) versus Group II recipients (4.4%; 6/136; p < 0.001). Single or repeated percutaneous drainage procedures successfully treated 35 Group I patients versus all 6 Group IV patients ( p = 0.033). No patients in Group II versus 21 patients in Group I underwent surgical procedures ( p < 0.001). A significantly higher rate and higher histologic grade of acute rejection episodes, particularly proximate to the onset of the lymphocele, occurred among Group IV patients, namely 54.2% (13/24) versus 21.4% (29/135) Group III patients ( p < 0.001). Additionally we report the case of a 29-year-old patient who underwent a lymphocele fenestration with omentoplasty 8 years after his transplantation. Despite an Influenza A + Chlamydia pneumonia and acute rejection which was followed by a GI bleeding and stomach resection he fully recovered and is doing well with an excellent kidney function a year after.

CONCLUSIONS

Addition of sirolimus to a cyclosporine-prednisone regimen resulted in both a higher incidence and a requirement for more aggressive treatment of perinephric fluid collections and/or lymphoceles with a much lower acute rejection frequency.

摘要

引言

淋巴囊肿是肾移植后的一种特殊并发症。作者研究了在接受西罗莫司治疗的肾移植受者中,与临床上显著的肾周液体积聚和/或淋巴囊肿发生率增加相关的因素。

目的

从淋巴囊肿的角度,比较传统免疫抑制方案和一种新的免疫抑制联合方案的风险和益处。

方法

在休斯顿的德克萨斯大学进行的一项回顾性研究中,比较了接受西罗莫司 - 环孢素 - 泼尼松治疗的患者(n = 354,第一组)与接受环孢素 - 泼尼松 - 硫唑嘌呤治疗的患者(n = 136,第二组)中这些液体积聚的发生率、易感因素和后果。

结果

第一组患者中出现肾周液体积聚的比例(135/354;38.1%)高于第二组患者(24/136;17.6%;p < 0.001)。在两个亚组中,诊断时血清肌酐水平均从最低点升高,第一组(接受西罗莫司治疗的第三组)从179.5±141.7 mmol/l升高至359.9±259.6 mmol/l,第二组(未接受西罗莫司治疗的第四组)从222.6±205.9 mmol/l升高至383.7±255.2 mmol/l。第一组患者(15.8%;56/354)中因淋巴囊肿需要治疗的人数明显多于第二组患者(4.4%;6/136;p < 0.001)。35例第一组患者和所有6例第四组患者通过单次或重复经皮引流手术成功治疗(p = 0.033)。第二组中无患者接受手术,而第一组中有21例患者接受了手术(p < 0.001)。第四组患者中急性排斥反应的发生率和组织学分级明显更高,尤其是在淋巴囊肿发作附近,第四组患者为54.2%(13/24),第三组患者为21.4%(29/135)(p < 0.001)。此外,我们报告了一例29岁患者,在移植8年后接受了淋巴囊肿开窗术加网膜成形术。尽管发生了甲型流感 + 衣原体肺炎和急性排斥反应,随后出现了胃肠道出血和胃切除术,但他完全康复,一年后肾功能良好。

结论

在环孢素 - 泼尼松方案中添加西罗莫司导致肾周液体积聚和/或淋巴囊肿的发生率更高,且需要更积极的治疗,同时急性排斥反应频率更低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验